In order to reflect his expectations for lower margins and higher interest costs, analyst Tom Jones has axed his earnings per share (EPS) forecast for the 2012-2016 period by between 6% and 10%.
At 1609 GMT today Rhoen-Klinikum's share lost 2.92% to EUR15.3 in floor trading on the Frankfurt Stock Exchange. The stock fell 2.57% to EUR15.28 at 1626 GMT on Xetra.
(EUR 1.0 = USD 1.308)
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development